Sage Journals: Discover world-class research

Retricted access

Other

First published 1995-4

Interim Analyses: An FDA Reviewer's Experience and Perspective *

A. J. Sankoh

Therapeutic Innovation & Regulatory Science

Retricted access

Other

First published 1999-1

Interim Analyses: An Update of an FDA Reviewer's Experience and Perspective *

A. J. Sankoh

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1986-7

Interim Analyses in Randomized Clinical Trials

Stuart J. Pocock, Nancy L. Geller

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2015-8

Plan to Have No Unplanned: A Collaborative,Hospital-Based Quality-Improvement Project to Reduce the Rate of Unplanned Extubations in the Pediatric ICU

Sandeep Tripathi, Denise J Nunez, Chaavi Katyal [...]

Respiratory Care

Retricted access

Research article

First published 2016-07

Perforated Appendicitis: Nurse Practitioner Follow-Up Telephone Calls Reducing Unplanned Return to Care With/Without Readmission

Ellen Ann O’Donnell, Rosella Micalizzi, Caitlin Phinney [...]

Journal of Pediatric Surgical Nursing

Retricted access

Research article

First published 2012-6

A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials

Yimei Li, Rosemarie Mick, Daniel F Heitjan

Clinical Trials

Free access

Research article

First published 2005-1

Early Virological Failure with a Combination of Tenofovir,Didanosine and Efavirenz

Daniel Podzamczer, Elena Ferrer, Josep Maria Gatell [...]

Antiviral Therapy

Open access

Research article

First published 2022-10

From policy to institution: Implementing land reform in Dar es Salaam’s unplanned settlements

Martina Manara

Environment and Planning A: Economy and Space

Free access

Announcement

First published 2006-7

Amdoxovir versus Placebo with Enfuvirtide plus Optimized Background Therapy for HIV-1-Infected Subjects Failing Current Therapy (Aactg A5118)

Barbara M Gripshover, Heather Ribaudo, Jorge Santana [...]

Antiviral Therapy

Open access

Research article

First published 2022

Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter,randomized,phase III trial (GAPSO study)

Yu-Hong Dai, Xiong-Jie Yu, Hui-Ting Xu [...]

Therapeutic Advances in Medical Oncology

Search results